Aemetis, Inc.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: US00770K2024
USD
1.63
0.04 (2.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Aemetis, Inc. stock-summary
stock-summary
Aemetis, Inc.
Specialty Chemicals
Aemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company's approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company's over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant.
Company Coordinates stock-summary
Company Details
20400 Stevens Creek Blvd Ste 700 , CUPERTINO CA : 95014-2296
stock-summary
Tel: 1 408 5173304
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 17 Schemes (13.79%)

Foreign Institutions

Held by 31 Foreign Institutions (3.29%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Eric McAfee
Chairman of the Board, Chief Executive Officer, Co-Founder
Dr. Naomi Boness
Director
Mr. Francis Barton
Independent Director
Ms. Lydia Beebe
Independent Director
Mr. John Block
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
52 Million
(Quarterly Results - Jun 2025)
Net Profit:
-23 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 143 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.63

stock-summary
Return on Equity

28.37%

stock-summary
Price to Book

-0.49